I |
HDAC 1 and HDAC2 |
unclear |
Trivedi et al. described that cardiac-specific double knock-out Hdac1/2 mice have dilated cardiomyopathy, arrhythmias, and neonatal lethality, accompanied by up-regulation of genes encoding skeletal muscle-specific myofibrillar proteins and calcium channels. Montogomery et al. did not detect any alteration of cardiac function of knock-out mice (see text). |
II |
HDAC 5 |
anti-hypertrophic |
Major sensibility to the development of cardiac hypertrophy and a failure in responding to pro-hypertrophy stimuli, such as TAC and calcineurin activation. |
HDAC 9 |
anti-hypertrophic |
Major sensibility to the development of cardiac hypertrophy and a failure in responding to pro-hypertrophy stimuli, such as TAC and calcineurin activation. |
III |
SIRT6 |
anti-hypertrophic |
Cardiac-specific double knock-out Sirt6 mice developed cardiac hypertrophy and heart failure; Sirt6 transgenic mice were protected from hypertrophic stimuli, such as TAC and isoproterenol infusion. |
SIRT3 |
anti-hypertrophic |
Sirt3 knock-out mice had an increased heart weight/body weight (HW/BW) ratio and interstitial fibrosis at 8 weeks of age; cardiac-specific Sirt3 transgenic mice were protected from hypertrophic stimuli, such angiotensin II infusion and isoproterenol infusion. |